XML 36 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue (Tables)
6 Months Ended
Jun. 30, 2018
Revenue from Contract with Customer [Abstract]  
Impact of ASC 606 in Current Period [Table Text Block]
The following tables represent the amounts by which each financial statement line item is affected in the current year as a result of applying ASC Topic 606 (in thousands):

 
For the three months ended
June 30, 2018
 
For the six months ended
June 30, 2018
 
As Reported
 
Without Adoption of ASC 606
 
Effect of Adoption
 
As Reported
 
Without Adoption of ASC 606
 
Effect of Adoption
Revenue
$
360,460

 
$
352,288

 
$
8,172

 
$
732,493

 
$
722,309

 
$
10,184

Cost of goods sold
$
208,660

 
$
207,640

 
$
1,020

 
$
431,692

 
$
430,651

 
$
1,041

Gross Profit
$
151,800

 
$
144,648

 
$
7,152

 
$
300,801

 
$
291,658

 
$
9,143

 
 
As of June 30, 2018
 
 
As Reported
 
Without Adoption of ASC Topic 606
 
Effect of Adoption
Prepaid expenses and other current assets
 
28,742

 
$
32,885

 
$
(4,143
)
Accrued liabilities
 
111,280

 
$
132,936

 
$
(21,656
)
Deferred income taxes
 
19,584

 
$
21,583

 
$
(1,999
)
Disaggregation of Revenue [Table Text Block]
The following table represents our revenues disaggregated by geography (in thousands):

 
For the three months
ended June 30,
 
For the six months
ended June 30,
Geography
2018
 
2017 (1)
 
2018
 
2017 (1)
EMEA
$
33,867

 
$
31,905

 
$
73,391

 
$
56,858

APAC
18,410

 
15,673

 
37,034

 
27,089

LATAM
15,557

 
19,208

 
28,650

 
25,685

North America
17,810

 
16,537

 
36,945

 
28,098

Other

 

 
80

 

Total Foreign
85,644

 
83,323

 
176,100

 
137,730

United States
274,816

 
248,191

 
556,393

 
441,523

Total Revenues
$
360,460

 
$
331,514

 
$
732,493

 
$
579,253


The following table represents our revenues disaggregated by product (in thousands):

 
For the three months ended
June 30,
 
For the six months ended
June 30,
Product line
2018
 
2017 (1)
 
2018
 
2017 (1)
Infusion Consumables
$
123,782

 
$
77,561

 
$
243,693

 
$
153,274

IV Solutions
135,325

 
134,414

 
279,765

 
231,784

Infusion Systems (2)
88,376

 
73,122

 
181,815

 
119,792

Critical Care
12,977

 
11,874

 
27,220

 
24,270

Other

 
34,543

 

 
50,133

Total Revenues
$
360,460

 
$
331,514

 
$
732,493

 
$
579,253

Contract with Customer, Asset and Liability [Table Text Block]
The following table presents our changes in the contract balances for the six months ended June 30, 2018 (in thousands):
 
Contract Liabilities
Beginning balance, January 1, 2018
$
(7,066
)
Equipment revenue recognized
1,971

Equipment revenue deferred due to implementation
(2,733
)
Software revenue recognized
4,685

Software revenue deferred due to implementation
(4,845
)
Ending balance, June 30, 2018
$
(7,988
)